Abiopharma

New Form SC14D9C - Turnstone Biologics Corp. Filed: 2025-06-27 AccNo: 0001193125-25-149768 Size: 37 KB

New Form 8-K - Ultragenyx Pharmaceutical Inc. Filed: 2025-06-27 AccNo: 0000950170-25-090616 Size: 152 KB Item 8.01: Other Events

Avantor, Inc. - Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025

Xpres Spa Named One of Yelp’s Most Loved Airport Brands

Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Calidi Biotherapeutics - Calidi Biotherapeutics Announces Shareholder Letter from CEO

New Form SC TO-C - Turnstone Biologics Corp. Filed: 2025-06-27 AccNo: 0001193125-25-149747 Size: 49 KB

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Schrödinger, Inc. - Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/RefractoryWaldenström Macroglobulinemia

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology